The Pharmacy Times® Eye Care resource center provides clinical news and articles, coverage from ophthalmology conferences and meetings, links to condition-specific resources, and videos and other content.
What can we help you find?
Seventeen states with medical marijuana laws saved Medicare Part D approximately $165.2 million in 2013.
Medicated ring shows better adherence rate and decreased eye pressure in patients with glaucoma or ocular hypertension.
Slow-binding inhibitors of cholinesterases could produce treatments for Alzheimer's disease, myasthenia, and neuroprotection.
Metformin use is associated with a reduced risk of glaucoma development among diabetics.
Glaucoma patients typically have ever-changing drug therapy regimens involving multiple eye drop products.
The FDA is reviewing a novel treatment for patients with open angle glaucoma or ocular hypertension.
Early detection and treatment are key to protecting eyesight.
This continuing education activity is supported by an unrestricted educational grant from Alcon, Inc.
Switching patients with glaucoma to generic medications can improve their adherence to ophthalmic drug therapies, according to researchers from the University of Michigan Kellogg Eye Center and College of Pharmacy.
Latanoprost eye drops may significantly reduce the risk of vision loss in patients with glaucoma.
Latanoprostene bunod (Vesneo) demonstrated noninferiority to timolol maleate (Timoptic 5%) in pivotal Phase 3 studies.